MedTrace Logo

Pulmonary Blood Flow Measurements in CHF Patients

NCT01831713 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2015-07-15

No results posted yet for this study

Summary

Historically, transthoracic Doppler echocardiography has been unable to provide interpretable data of blood flow within the lung parenchyma because of air attenuation of Doppler signals. Recently, a transthoracic Doppler system known as the Sonara/tek Transcranial Doppler (TCD) System has been developed that can identify parenchymal pulmonary blood flow (PPBF) signals. The ability to non-invasively collect information regarding the pulmonary aspect of the cardio-pulmonary system may provide valuable information and new insights into the structural and functional characteristics of the lung parenchyma and vasculature in health and disease states.

Conditions

  • Congestive Heart Failure (CHF)

Sponsors & Collaborators

  • Echosense Ltd.

    lead INDUSTRY

Principal Investigators

  • Jennifer Chen, MD · Lenox Hill Hospital, 100East 77 Street New York, NY 10075

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2015-04-30
Completion
2015-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01831713 on ClinicalTrials.gov